Welcome to LookChem.com Sign In|Join Free

CAS

  • or

935854-36-7

Post Buying Request

935854-36-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

935854-36-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 935854-36-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,8,5 and 4 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 935854-36:
(8*9)+(7*3)+(6*5)+(5*8)+(4*5)+(3*4)+(2*3)+(1*6)=207
207 % 10 = 7
So 935854-36-7 is a valid CAS Registry Number.

935854-36-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H66350)  3-[2-(Ethoxycarbonyl)ethyl]benzeneboronic acid pinacol ester, 97%   

  • 935854-36-7

  • 1g

  • 882.0CNY

  • Detail
  • Alfa Aesar

  • (H66350)  3-[2-(Ethoxycarbonyl)ethyl]benzeneboronic acid pinacol ester, 97%   

  • 935854-36-7

  • 5g

  • 2352.0CNY

  • Detail

935854-36-7Downstream Products

935854-36-7Relevant articles and documents

THERAPEUTIC AGENTS TARGETING GPR35

-

Paragraph 00151; 00158, (2022/02/05)

Described herein are GPR35 modulators and methods of using these compounds in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.

3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors

-

Page/Page column 26-27, (2012/01/03)

New pyridazin-3(2H)-one derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of the phosphodiesterase IV (PDE4).

(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors

-

Page/Page column 54, (2010/07/03)

New (3-oxo)pyridazin-4-ylurea derivatives having the chemcial structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of the phosphodiesterase IV (PDE4).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 935854-36-7